C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2006
12/05/2006	US7144997 Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto
12/05/2006	US7144911 Anti-inflammatory medicaments
12/05/2006	US7144910 hydrolase enzyme antagonists such as N-{(6S,9R,11R)-2-[5-4-fluoroophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-6,9-methanobenzo[a][8]annulen-11-yl}-N'-(2,2,2-trifiuoroethyl)sulfamide that inhibit processing of amyloid precursor protein, useful in treating or preventing Alzheimer's disease
12/05/2006	US7144903 CCR4 antagonists
12/05/2006	US7144900 Pharmaceutical composition
12/05/2006	US7144899 Thrombin inhibitors
12/05/2006	US7144898 Indole derivatives for the treatment of depression and anxiety
12/05/2006	US7144896 heterocyclic imines such as 3-[6-(1-Methanesulfonyl-1-methyl-ethyl)-quinolin-8-yl]-N-[6-(4-methylsulfanyl-phenyl)-pyridin-3-yl]-benzamide, used as phosphodiesterases (pde4) inhibitors; side effect reduction
12/05/2006	US7144895 Benzene acetamide compounds useful as serine protease inhibitors
12/05/2006	US7144889 Triarylimidazoles
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144886 Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents
12/05/2006	US7144882 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
12/05/2006	US7144880 Compositions relating to novel compounds and targets thereof
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/05/2006	CA2293713C Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
12/05/2006	CA2245728C Isoquinoline derivatives and drugs
12/05/2006	CA2203079C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents
12/05/2006	CA2203078C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents
12/05/2006	CA2189652C Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same
11/2006
11/30/2006	WO2006128120A2 Novel lapachone compounds and methods of use thereof
11/30/2006	WO2006127926A2 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
11/30/2006	WO2006127576A2 N - formyl hydroxylamine compounds as pdf inhibitors
11/30/2006	WO2006127396A1 Par2-modulating compounds and their use
11/30/2006	WO2006127379A2 Par2-modulating compounds and their use
11/30/2006	WO2006127329A1 Quinoline derivatives useful as modulators of ion channels
11/30/2006	WO2006127207A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
11/30/2006	WO2006127205A2 Methods of preparing 3-cyano-quinolines and intermediates made thereby
11/30/2006	WO2006126939A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006126695A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	WO2006126676A1 Cyclic amine derivative having substituted alkyl group
11/30/2006	WO2006125665A1 Substituted piperidine antagonist of hi receptor to be used for the treatment of rhinitis
11/30/2006	WO2006125641A2 Pyridine compounds for combating arthropod pests and nematodes
11/30/2006	WO2006125621A1 Substituted piperidines as renin inhibitors
11/30/2006	WO2006113261A3 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
11/30/2006	WO2006099301A3 Apoptosis inhibitors
11/30/2006	WO2006009726A3 Substituted urea derivatives for treating cardiac diseases
11/30/2006	US20060270854 Crystalline form of a benzimidazole-carboxamide medicinal compound
11/30/2006	US20060270713 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/30/2006	US20060270706 Cyclic amine derivative having heteroaryl ring
11/30/2006	US20060270704 potassium channel modulators such as 4-(3-fluorophenyl)-6-methoxy-N,N,2-trimethyl-1-oxo-1,2-dihydroisoquinoline-3-carboxamide, used as antiarrhythmia agents; cardiovascular disorders
11/30/2006	US20060270693 Ether derivative
11/30/2006	US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006	US20060270683 Polymorphs of aripiprazole
11/30/2006	US20060270681 Pyridazine derivatives
11/30/2006	US20060270673 Inhibitors of akt activity
11/30/2006	US20060270672 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
11/30/2006	US20060270660 Processes for preparing substituted pyrimidines
11/30/2006	US20060270657 N-substituted heterocyclic sulfonamides
11/30/2006	US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006	US20060267488 electroluminescent thin films containing anthracene derivatives between anodes and cathodes, used as light emitters ahving efficiency and durability
11/30/2006	CA2609852A1 Cyclic amine derivative having substituted alkyl group
11/30/2006	CA2609747A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609394A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	CA2609353A1 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
11/30/2006	CA2609186A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
11/30/2006	CA2608685A1 Substituted piperidines as renin inhibitors
11/30/2006	CA2608634A1 N-formyl hydroxylamine compounds as pdf inhibitors
11/30/2006	CA2608394A1 Methods of preparing 3-cyano-quinolines and intermediates made thereby
11/30/2006	CA2607280A1 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
11/29/2006	EP1726590A1 Cycloalkanopyridine derivative
11/29/2006	EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006	EP1726584A1 2-aminoquinazoline derivative
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1726306A1 Fasudil-containing preparation and method of improving stability thereof
11/29/2006	EP1726305A1 Zinc salt of omeprazole and its enantiomers
11/29/2006	EP1725564A1 M3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725550A2 Pyrrole-derivatives as factor xa inhibitors
11/29/2006	EP1725545A1 Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof
11/29/2006	EP1725544A1 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
11/29/2006	EP1725543A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/29/2006	EP1725542A1 Vla-4 antagonists
11/29/2006	EP1725538A1 Pyridazinone ureas as antagonists of a4 integrins
11/29/2006	EP1725535A2 Hiv integrase inhibitors
11/29/2006	EP1725534A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
11/29/2006	EP1725530A1 Organic compounds
11/29/2006	EP1725528A2 Sulphonylpyrroles as hdac inhibitors
11/29/2006	EP1725241A1 M3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725240A1 Muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725239A1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
11/29/2006	EP1725238A2 M 3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725235A1 Piperidine derivatives useful as ccr3 antagonists
11/29/2006	EP1725103A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
11/29/2006	EP1572207A4 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
11/29/2006	EP1553947A4 Quinazolinones and derivatives thereof as factor xa inhibitors
11/29/2006	EP1114028B1 Aza-bicycles which modulate the inhibition of cell adhesion
11/29/2006	EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	EP0699194B1 5-ht4 receptor antagonists
11/29/2006	CN1871237A 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-IV inhibitors
11/29/2006	CN1871236A Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders
11/29/2006	CN1871232A Benzimidazolyl derivatives
11/29/2006	CN1871231A 吡嗪衍生物及其医药用途 Pyrazine derivatives and pharmaceutical use
11/29/2006	CN1871225A Preferentially substituted calcium channel blockers
11/29/2006	CN1871222A Ccr3受体拮抗剂 Ccr3 receptor antagonists
11/29/2006	CN1871009A 5-arylpyrimidines as anticancer agents
11/29/2006	CN1871008A Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
11/29/2006	CN1871007A Process for making sterile aripiprazole of desired mean particle size
11/29/2006	CN1871005A 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators

1 ... 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 ... 1080